Cephalosporin-Based Prophylaxis: New Evidence Reveals Superior Outcomes After Colorectal Surgery

Are your current perioperative antibiotic choices giving your patients the best chance at avoiding surgical site infections (SSIs) after colorectal surgery? SSIs remain one of the most common and costly complications in elective colorectal procedures, with incidence rates reaching up to 25%. Given the high stakes for both patients and institutions, optimal prophylactic strategies are more relevant than ever.

Study Overview: What Was Done and Why It Matters

A large-scale systematic review and network meta-analysis published in JAMA Network Open assessed data from 105 randomized clinical trials including over 18,000 patients undergoing elective colorectal surgery. Unlike previous reviews that focused mostly on timing or route, this study directly compared various antibiotic classes and combinations given within 24 hours preoperatively. The goal was to identify which regimens best prevent SSIs, reduce mortality, and minimize adverse effects.

Key Findings: Which Antibiotics Stand Out?

Broad-spectrum penicillins (e.g., ampicillin-sulbactam, amoxicillin-clavulanate) showed the strongest association with reduced SSI risk compared to placebo (RR, 0.26; 95% CI, 0.16–0.42).

Third-generation cephalosporins, combinations of metronidazole with a second-generation cephalosporin, and tetracyclines also significantly reduced SSI rates.

Notably, broad-spectrum penicillins were the only class associated with a statistically significant reduction in 30-day postoperative mortality (RR, 0.21; 95% CI, 0.05–0.90).

No significant differences in SSI prevention were found among other regimens, including standard penicillins or aminoglycoside-based combinations.

Adverse Events and Hospital Stay: A Level Playing Field

Despite differences in efficacy for SSI prevention, no antibiotic regimen significantly affected the risk of adverse events or the length of hospital stay. This finding held true across all antibiotic classes and combinations examined, suggesting that safety and efficiency in discharge timing may not be the main differentiators in regimen selection for this patient group.

Clinical Implications: What Should Surgeons and Teams Do?

This study underscores the importance of antibiotic class selection—not just timing or route—in SSI prophylaxis for colorectal surgery. For clinicians, regimens containing broad-spectrum penicillins or cephalosporin-metronidazole combinations should be strongly considered, especially in settings where guideline-concordant options are available. At the same time, choice should be balanced with local resistance patterns and individual patient risk factors.

Limitations: What Can’t We Say (Yet)?

While the evidence for broad-spectrum penicillins is compelling, limitations such as variable reporting of comorbidities, inconsistent definitions of adverse events, and occasional high risk of bias in included studies mean that results should be interpreted with some caution. Ultimately, individualized patient care and antimicrobial stewardship remain essential.

Conclusion

For elective colorectal surgery, evidence now clearly favors broad-spectrum penicillins and certain cephalosporin-based combinations for SSI prevention, with potential mortality benefits. Surgeons should weigh these findings alongside local practice patterns and resistance profiles when updating prophylactic protocols.

Key Points

Broad-spectrum penicillins offer the greatest protection against surgical site infections after elective colorectal surgery.

Third-generation cephalosporins and cephalosporin-metronidazole combinations are also highly effective.

Only broad-spectrum penicillins showed a significant mortality benefit compared to placebo.

No antibiotic regimen stood out for reducing adverse events or shortening hospital stay.

Antibiotic class selection, alongside local resistance and patient factors, is crucial for optimal SSI prophylaxis.

Citation:

Motaghi S, Karam SG, Mulazzani F, et al. Antibiotic Prophylaxis Strategies and Surgical Site Infections in Colorectal Surgery: A Systematic Review and Network Meta-Analysis. JAMA Network Open. 2026;9(2):e2560095. doi:10.1001/jamanetworkopen.2025.60095